Athersys Inc Alliance for Regenerative Medicine - Cell & Gene Webinar Series: Cell Therapy Treatments for COVID-19
שיחת ועידה Athersys Inc
Athersys Inc Conference call or earnings call will be held on 21/05/2020 via an 800 number (toll-free). During the earnings conference call's session Athersys Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Athersys Inc for this information
Schedule a teleconference with QCONF and get 5 free calls with our conference service.
We are an international biotechnology company that is focused primarily in the field of regenerative medicine. We are committed to the discovery and development of best-in-class therapies designed to extend and enhance the quality of human life. We have established a portfolio of therapeutic product development programs to address significant unmet medical needs in multiple disease areas. Our MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is our lead platform product and is currently in later-stage clinical development. Our current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients. These represent major areas of clinical need, as well as substantial commercial opportunities.קרא עוד שיחת ועידה